Floatz logo

Tysabri

Progressive Multifocal Leukoencephalopathy

BiogenDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Progressive Multifocal Leukoencephalopathy cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Tysabri is also rated in:

relapsing-remitting multiple sclerosisDormant
B
Indicative ·
62 / 100
View asset →
multiple sclerosisDormant
D
Indicative ·
28 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →